Health and Healthcare
5864 Articles
Biotech giant Alexion Pharmaceuticals announced Wednesday morning that it will acquire Synageva BioPharma.
Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.
Array BioPharma released disappointing fiscal third-quarter earnings before the markets opened Monday morning.
In a new report, the analysts at Stifel are very positive on two companies leading the charge against antibiotic-resistant "super…
Immunomedics may be poised to make big moves going forward in 2015, according to Wells Fargo.
Recently, biotech stocks have been getting stung pretty good, and now may be a good time to look at companies…
Gilead Sciences reported better than expected first-quarter results Thursday after the markets closed.
A lot of times when companies have secondary offerings the price takes a slight dip to accommodate the dilution and…
In a new report, Stifel sees two biotech stocks with near-term catalysts that could make takeover candidates soon.
Celgene released mixed first-quarter results before the markets opened Thursday and shares were down in early trading.
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) will report its first-quarter earnings Thursday after the markets close. Thomson Reuters has consensus estimates…
ThinkstockCelgene Corp. (NASDAQ: CELG) is scheduled to release its first-quarter financial results before the markets open Thursday. Thomson Reuters has…
ThinkstockThe trend towards generic drugs is nothing new. It does not matter if a drug has billions of dollars in…
Merck has managed to beat its first-quarter earnings expectations, and handily at that.
Pfizer has reported better-than-expected first-quarter earnings and revenue and offered guidance.
Our top personal finance-related articles today. Your wallet will thank you later.